High Court stays Rs 1.35 cr demand slapped on Novartis by NPPA
Novartis, in its plea, claimed that the government by a June 14, 2013 notification had revised the price of its drug, Regestrone, used for regulating women's menstrual cycle.
Jun 01, 2015, 17:15 PM IST